descriptive
Analysis v1
Strong Support
When people with obesity take retatrutide, the most common side effects are stomach problems like nausea or diarrhea. These tend to happen more and get worse when the dose is higher, but starting with a lower dose (2 mg) might help reduce these issues.
61
0
Evidence from Studies
Supporting (1)
61
Community contributions welcome
61
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.
Randomized Controlled Trial
Human
2023 Aug 10The study looked at the same drug and found that stomach-related side effects were the most common, got worse with higher doses, and were less likely when people started on a lower dose — just like the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.